Regarding naltrexone for probationers and parolees.
Stancliff
Sharon
S
D002047:Buprenorphine / Q000009:adverse effects / Q000627:therapeutic use; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D007267:Injections; D008134:Long-Term Care; D008691:Methadone / Q000009:adverse effects / Q000627:therapeutic use; D009271:Naltrexone / Q000009:adverse effects / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D009294:Narcotics / Q000009:adverse effects / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D011329:Prisoners / Q000523:psychology*; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D009294:Narcotics; D002047:Buprenorphine; D009271:Naltrexone; D008691:Methadone